CSC
FLGT icon

Caldwell Sutter Capital’s Fulgent Genetics FLGT Stock Holding History

Caldwell Sutter Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35
Closed -$1.01K – 944
2023
Q4 		$1.01K Buy
+35
New +$936 ﹤0.01% 829

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Caldwell Sutter Capital's FLGT Position: Q1 2024 in Review

Caldwell Sutter Capital sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 35 shares — an estimated $1.01K sold.

Caldwell Sutter Capital first reported a position in FLGT in Q4 2023 and held it in 1 quarter. The position peaked at $1.01K in Q4 2023. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Caldwell Sutter Capital reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • Caldwell Sutter Capital sold 35 Fulgent Genetics shares in Q1 2024, an estimated $1.01K.
  • Caldwell Sutter Capital first reported a position in Fulgent Genetics in Q4 2023 and held it in 1 quarter.
  • Caldwell Sutter Capital's Fulgent Genetics position peaked at $1.01K in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Caldwell Sutter Capital's 13F filing for Q1 2024, filed 19 Apr 2024.